Dicot Pharma AB (STO:DICOT)

Dicot Pharma AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Selling, General & Admin	73.84	82.44	59.06	45.03	31.67	27.13
Other Operating Expenses	0.29	0.19	0.21	-0	0.13	0.11
Operating Expenses	74.12	82.62	59.28	45.03	31.8	27.25
Operating Income	-74.12	-82.62	-59.28	-45.03	-31.8	-27.25
Interest Expense	-0.01	-0.01	-0.01	-0.07	-0.03	-0
Interest & Investment Income	2.23	2.23	1.57	0.91	-	0
Currency Exchange Gain (Loss)	0.16	0.16	0.03	0.03	0.08	0.05
Other Non Operating Income (Expenses)	-0.4	0	-	-	-	-
EBT Excluding Unusual Items	-72.14	-80.24	-57.7	-44.16	-31.76	-27.2
Gain (Loss) on Sale of Assets	-	-	-	-	-	0.03
Pretax Income	-72.14	-80.24	-57.7	-44.16	-31.76	-27.17
Net Income	-72.14	-80.24	-57.7	-44.16	-31.76	-27.17
Net Income to Common	-72.14	-80.24	-57.7	-44.16	-31.76	-27.17
Shares Outstanding (Basic)	-	1,947	1,091	530	120	64
Shares Outstanding (Diluted)	-	1,955	1,091	530	121	64
Shares Change (YoY)	-	79.20%	105.97%	336.53%	89.21%	124.32%
EPS (Basic)	-	-0.04	-0.05	-0.08	-0.26	-0.42
EPS (Diluted)	-	-0.04	-0.05	-0.08	-0.26	-0.42
Free Cash Flow	-78.45	-85.85	-58.87	-45.23	-29.71	-25.87
Free Cash Flow Per Share	-	-0.04	-0.05	-0.09	-0.24	-0.40
EBITDA	-	-82.62	-59.27	-45.03	-31.79	-27.24
D&A For EBITDA	-	0.01	0.01	0.01	0.01	0.01
EBIT	-74.12	-82.62	-59.28	-45.03	-31.8	-27.25
Revenue as Reported	0.16	0.16	0.03	0.23	0.12	0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.